Display options
Cite
Joergensen NL, Gabrielsen A, Lind M, et al. Gradient Fractionated Separation of Chondrogenically Committed Cells Derived from Human Embryonic Stem Cells. Biores Open Access. 2015;4(1):109-14doi: 10.1089/biores.2014.0051.
Joergensen, N. L., Gabrielsen, A., Lind, M., & Lysdahl, H. (2015). Gradient Fractionated Separation of Chondrogenically Committed Cells Derived from Human Embryonic Stem Cells. BioResearch open access, 4(1), 109-14. https://doi.org/10.1089/biores.2014.0051
Joergensen, Natasja Leth, et al. "Gradient Fractionated Separation of Chondrogenically Committed Cells Derived from Human Embryonic Stem Cells." BioResearch open access vol. 4,1 (2015): 109-14. doi: https://doi.org/10.1089/biores.2014.0051
Joergensen NL, Gabrielsen A, Lind M, Lysdahl H. Gradient Fractionated Separation of Chondrogenically Committed Cells Derived from Human Embryonic Stem Cells. Biores Open Access. 2015 Jan 01;4(1):109-14. doi: 10.1089/biores.2014.0051. eCollection 2015. PMID: 26309787; PMCID: PMC4497648.
Copy Download .nbib Format: NLM
Share it on

Biores Open Access. 2015 Jan 01;4(1):109-14. doi: 10.1089/biores.2014.0051. eCollection 2015.

Gradient Fractionated Separation of Chondrogenically Committed Cells Derived from Human Embryonic Stem Cells.

BioResearch open access

Natasja Leth Joergensen, Anette Gabrielsen, Martin Lind, Helle Lysdahl

Affiliations

  1. Orthopaedic Research Laboratory, Aarhus University Hospital , Aarhus, Denmark .
  2. Ciconia Aarhus Private Hospital , Aarhus, Denmark .
  3. Sports Trauma Clinic, Aarhus University Hospital , Aarhus, Denmark .

PMID: 26309787 PMCID: PMC4497648 DOI: 10.1089/biores.2014.0051

Abstract

Cartilage regeneration is a fast growing field that combines biotechnology and molecular techniques in creating new tissue mimicking the native microenvironment. Human embryonic stem cells (hESCs) are a highly potent cell source for cartilage regeneration owing to their infinite proliferation capacity and pluripotency. Thus, lineage-specific differentiation of hESCs often results in populations with cellular heterogeneity. Chondrogenesis was induced through high-density micromass culture of hESCs and by addition of chondrogenic medium; 1:100 ITS(+), 100 nM dexamethasone, 40 μg/ml l-proline, 50 μg/mL ascorbic acid-2-phosphate, 1:100 Knockout serum, and 10 ng/mL TGFβ3. At day 14 micromasses were dissociated and chondrogenically committed cell separated in a fraction-based discontinuous density gradient. After fractionation the chondrogenically committed cells were analyzed with regard to embryonic- and chondrogenic gene expression and fraction F3 and F4 with histology. In general, we found that the chondrogenic condition compared with the control condition had a significant effect on the following gene expression levels: NANOG, OCT4, SOX5, SOX9, ACAN, and COL2A1 in all fractions. Furthermore, we found in the chondrogenic condition that NANOG, OCT4, and SOX9 were significantly higher in F4 compared with F3, whereas COL2A1 and the ratio COL2A1:COL1A1 were significantly lower. Additionally, toluidine blue pH 4 stains of pellet cultures of F3 and F4 revealed that cells from F3 were more homogenous in morphology than F4. In conclusion, we propose a simple strategy to obtain more homogenous population of chondrogenically committed cells from hESCs using micromass culture and discontinuous density gradient separation.

Keywords: Human embryonic stem cells; chondrogenic commitment; gradient fractionation; micromass culture

References

  1. Bone Marrow Transplant. 1987 Feb;1(3):281-8 - PubMed
  2. Reprod Biomed Online. 2008 May;16(5):730-40 - PubMed
  3. In Vitro Cell Dev Biol Anim. 1999 May;35(5):262-9 - PubMed
  4. Eur J Cell Biol. 1985 Nov;39(1):136-41 - PubMed
  5. Stem Cell Rev. 2009 Dec;5(4):428-34 - PubMed
  6. Exp Hematol. 2007 Feb;35(2):335-41 - PubMed
  7. Hum Reprod. 1999 Mar;14(3):759-64 - PubMed
  8. Stem Cells. 2007 Feb;25(2):425-36 - PubMed
  9. Reprod Biomed Online. 2006 Jan;12 (1):119-26 - PubMed
  10. J Cell Mol Med. 2009 Sep;13(9B):3570-90 - PubMed
  11. Methods Mol Biol. 2010;584:317-31 - PubMed
  12. Biotechnol Lett. 2010 Sep;32(9):1339-46 - PubMed
  13. Stem Cell Res. 2009 May;2(3):198-210 - PubMed
  14. Tissue Eng. 2006 Jun;12(6):1687-97 - PubMed
  15. Stem Cell Rev. 2013 Apr;9(2):132-9 - PubMed
  16. PLoS One. 2008 Jun 25;3(6):e2498 - PubMed
  17. J Biomed Mater Res A. 2010 Aug;94(2):539-46 - PubMed
  18. Am J Sports Med. 2009 Jul;37(7):1344-50 - PubMed

Publication Types